S052 Skinternal Medicine: An Update on Cutaneous Manifestations of Systemic Disease
DESCRIPTION
This is a case-based discussion of complex dermatologic problems that have systemic implications. We will utilize an Audience Response System for this session and therefore, Handouts will NOT be provided prior to the session. Speakers will be asked to upload a handout after the session.
LEARNING OBJECTIVES
Diagnose skin diseases that are associated with internal manifestations more effectively.
Develop an appropriate, yet cost effective, method of evaluation for patient with complex medical/dermatological disease.
Formulate an evidence-based management plan for patients with complex medical/dermatological disease.
SCHEDULE
1:00 PM
Introduction
Jeffrey Phillip Callen, MD, FAAD
1:05 PM
Case 1
Jean L. Bolognia, MD, FAAD
1:20 PM
Case 2
Cindy Owen, MD, FAAD
1:35 PM
Case 3
Courtney Reynolds Schadt, MD, FAAD
1:50 PM
Q&A
Jeffrey Phillip Callen, MD, FAAD, Jean L. Bolognia, MD, FAAD, Cindy Owen, MD, FAAD, Courtney Reynolds Schadt, MD, FAAD
2:00 PM
Case 4
Robert S. Kirsner, MD, PhD, FAAD
2:15 PM
Case 5
Dedee F. Murrell, MD, FAAD
2:30 PM
Case 6
2:40 PM
Q&A
Robert S. Kirsner, MD, PhD, FAAD, Dedee F. Murrell, MD, FAAD
2:55 PM
Case 7
3:05 PM
Case 8
Virginia Kartha, MD, FAAD
3:20 PM
Case 9
Erik Joseph Stratman, MD, FAAD
3:35 PM
Case 10
Ruth Ann Vleugels, MD, MBA, MPH, FAAD
3:50 PM
Q&A
Virginia Kartha, MD, FAAD, Erik Joseph Stratman, MD, FAAD, Ruth Ann Vleugels, MD, MBA, MPH, FAAD
DIRECTOR
Jeffrey Phillip Callen, MD, FAAD
University of Louisville Sch of Medicine
SPEAKERS
Jean L. Bolognia, MD, FAAD
Yale School of Medicine
Virginia Kartha, MD, FAAD
University of Louisville
Robert S. Kirsner, MD, PhD, FAAD
Dedee F. Murrell, MD, FAAD
UNSW Sydney Australia
Cindy Owen, MD, FAAD
Courtney Reynolds Schadt, MD, FAAD
Erik Joseph Stratman, MD, FAAD
Marshfield Clinic Region- Sanford Health
Ruth Ann Vleugels, MD, MBA, MPH, FAAD
Penn Medicine
DISCLOSURES
Jean L. Bolognia, MD, FAAD
Elsevier Inc. – Other(Patent royalties or other compensation for Intellectual Property Rights);
Jeffrey Phillip Callen, MD, FAAD
3M Pharmaceuticals – Stockholder Public Company(No Compensation Received); Abbott Laboratories – Stockholder Public Company(No Compensation Received); AbbVie – Stockholder Public Company(No Compensation Received); Allergan, Inc – Stockholder Public Company(No Compensation Received); Amgen – Stockholder Public Company(No Compensation Received); Biogen – Data Safety Monitoring Board(Honoraria); Celgene – Stockholder Public Company(No Compensation Received); Elsevier Inc. – Other(Other Financial Benefit); JAMA – Other(No Compensation Received); Johnson and Johnson – Stockholder Public Company(No Compensation Received); Merck & Co., Inc – Stockholder Public Company(No Compensation Received); Pfizer Inc. – Stockholder Public Company(No Compensation Received); Procter & Gamble Company – Stockholder Public Company(No Compensation Received); Proivant – Data Safety Monitoring Board(Fees); UpToDate, Inc. – Other(Honoraria);
Virginia Kartha, MD, FAAD
No financial relationships exist with ineligible companies.
Robert S. Kirsner, MD, PhD, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria); BioStem Technologies – Consultant (1099 relationship)(Honoraria); Boehringer Ingelheim – Investigator(Grants/Research Funding); BPGbio – Consultant (1099 relationship)(Honoraria); Kenvue – Consultant (1099 relationship)(Honoraria); Kerecis Limited – Advisory Board(Honoraria); LEO Laboratories Ltd (LEO Pharma) – Advisory Board(Honoraria); MediWound – Investigator(Grants/Research Funding); Organogenesis, Inc. – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); PolarityBio – Consultant (1099 relationship)(Honoraria); Smith & Nephew – Advisory Board(Honoraria); SolasCure – Consultant (1099 relationship)(Honoraria); Urgo Group – Advisory Board(Honoraria);
Dedee F. Murrell, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Actavis – Speaker/Faculty Education(Honoraria); Almirall – Consultant(Honoraria); Alumis – Investigator(Fees); Amgen – Investigator(Fees); Amicus Therapeutics – Advisory Board(Honoraria); Amryt Pharma – Investigator(Fees); Anacor Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); Apogee Therapeutics – Investigator(Fees); Arena Pharmaceuticals – Investigator(Grants/Research Funding); arGEN-X – Investigator(Fees); Ascent Pharmaceuticals – Speaker(Honoraria); Attovia Therapeutics – Investigator(Fees); Bambusa Therapeutics Inc – Advisory Board(Fees); BMS – Investigator(Fees); Castle Creek Pharmaceuticals – Consultant(Fees); Chiesi Farmaceutici – Advisory Board(Fees); CSL – Speaker(Honoraria); Delfin Technology – Investigator(Equipment); Eli Lilly and Company – Advisory Board(Honoraria); Evelo Biosciences, Inc. – Investigator(Fees); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding), Investigator(Other Financial Benefit); Incyte – Investigator(Fees); Johnson & Johnson – Investigator(Grants/Research Funding); Krystal Biotech, Inc – Other(No Compensation Received); L'Oreal – Speaker(Fees); Leo Pharma Inc – Speaker/Faculty Education(Honoraria); Medimmune – Investigator(Fees), Investigator(Grants/Research Funding); Nektar Therapeutics – Investigator(Fees); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Ono – Advisory Board(Fees); Pfizer Inc. – Investigator(Grants/Research Funding); Pierre Fabre Dermo-Cosmétique US – Speaker(Honoraria); Principia Biopharma Inc – Consultant(Honoraria); RAPT Therapeutics – Advisory Board(Fees); Regeneron Pharmaceuticals Inc – Advisory Board(Fees); RHEACELL – Data Safety Monitoring Board(Fees); Roche Laboratories – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Sanofi – Advisory Board(Fees), Investigator(Fees), Investigator(Grants/Research Funding); Schering-Plough Corporation – Investigator(Grants/Research Funding); Shire – Advisory Board(Honoraria), Investigator(Grants/Research Funding); TWi Biotechnology, Inc. – Advisory Board(Fees), Investigator(Fees); UCB – Investigator(Fees); UpToDate – Other(Fees);
Cindy Owen, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Alumis – Investigator(Grants/Research Funding); Amgen – Investigator(Grants/Research Funding); Bluefin – Investigator(Grants/Research Funding); Eli Lilly and Company – Investigator(Grants/Research Funding); Galderma – Investigator(Grants/Research Funding); Incyte – Investigator(Grants/Research Funding); MoonLake Immunotherapeutics – Investigator(Grants/Research Funding); Nektar Therapeutics – Investigator(Grants/Research Funding); Novartis – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Investigator(Grants/Research Funding); Teva Pharmaceutical Industries Ltd. – Investigator(Grants/Research Funding); Veradermics – Investigator(Grants/Research Funding); Zura Bio – Investigator(Grants/Research Funding);
Courtney Reynolds Schadt, MD, FAAD
No financial relationships exist with ineligible companies.
Erik Joseph Stratman, MD, FAAD
UpToDate, Inc – Other(Honoraria);
Ruth Ann Vleugels, MD, MBA, MPH, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Astra Zeneca – Consultant (1099 relationship)(Honoraria); Biogen – Consultant (1099 relationship)(Honoraria); BMS – Consultant (1099 relationship)(Honoraria); Eli Lilly – Consultant (1099 relationship)(Honoraria); Priovant Therapeutics – Consultant (1099 relationship)(Honoraria);